P425: Comparison of therapeutic choices in biologic experienced Crohn’s disease and ulcerative colitis patients in Europe: discontinuation rates because of disease improvementsECCO '16 Amsterdam
2016
P426: Post-induction adalimumab drug levels predict clinical and laboratory remission at week 24 in patients with Crohn’s diseaseECCO '16 Amsterdam
2016
P427: The real-life experience of vedolizumab efficacy and safety in Crohn’s disease: a prospective observational multicentre cohort studyECCO '16 Amsterdam
2016
P428: Tofacitinib pharmacokinetics and durability of drug exposure in moderate-to-severe Crohn’s disease patients in Phase 2 induction and maintenance studiesECCO '16 Amsterdam
2016
P429: The effects of psychiatric treatment in patients with inflammatory bowel disease: a prospective studyECCO '16 Amsterdam
2016
P430: Prognostic significance of serial faecal calprotectin in inflammatory bowel diseaseECCO '16 Amsterdam
2016
P431: Transabdominal ultrasonography to assess intestinal wall thickness and vascularity appears to predict therapeutic effects of steroid treatment in moderate-to-severe ulcerative colitis patientsECCO '16 Amsterdam
2016
P432: Patient perspectives on biosimilars: a European Federation of Crohn’s and Colitis Associations surveyECCO '16 Amsterdam
2016
P433: Canadian patient and caregiver perspectives on subsequent entry biologics / biosimilars for inflammatory bowel diseaseECCO '16 Amsterdam
2016
P434: Close rectal versus total mesorectal excision in patients with inflammatory bowel disease undergoing proctocolectomy or completion proctectomyECCO '16 Amsterdam
2016
P435: Liver injury associated with anti-tumour necrosis factor therapy in paediatric irritable bowel disease patientsECCO '16 Amsterdam
2016
P436: Adalimumab dose escalation is effective and well tolerated in Crohn’s disease patients with secondary loss of response to adalimumabECCO '16 Amsterdam
2016
P437: Confidence, acceptance, and friendship: the 3 winners at Camp Purple Live 2015ECCO '16 Amsterdam
2016
P438: The inflammatory bowel disease disability index applied to ileal pouch anal anastomoses in New ZealandECCO '16 Amsterdam
2016
P439: Effectiveness of a training programme on motivational interviewing skills applied to inflammatory bowel disease managementECCO '16 Amsterdam
2016
P441: Conjoint analysis for quantification of inflammatory bowel disease patients’ preferences for outcome metricsECCO '16 Amsterdam
2016
P442: Evaluation of safety and efficacy of laparoscopic surgery for ulcerative colitisECCO '16 Amsterdam
2016